SCHEMBL9995320

SCHEMBL9995320

CCOC(=O)CN(C)C(=O)Cc1ccccc1Oc1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 8/20 0.52
SLC6A2 P23975 6/20 0.52
SLC6A3 Q01959 6/20 0.52
HTR2A P28223 4/20 0.52
PPARA Q07869 1/20 0.45
SLC1A5 Q15758 1/20 0.43
CHRM1 P11229 1/20 0.40
POLB P06746 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 1/20 0.39
CYP2D6 P10635 1/20 0.39
CXCL8 P10145 1/20 0.39
SIGMAR1 Q99720 1/20 0.38
KCNH2 Q12809 1/20 0.38
TP53 P04637 1/20 0.38
MDM2 Q00987 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL872624 0.89 SLC6A4 (0.53) SLC6A4SLC6A2SLC6A3HTR2APPARA
SCHEMBL878121 0.88 SLC6A4 (0.47) SLC6A4SLC6A2SLC6A3HTR2APPARA
SCHEMBL8471261 0.87 SLC6A4 (0.58) SLC6A4SLC6A2SLC6A3HTR2APPARA
SCHEMBL1146416 0.86 HTR2A (0.54) SLC6A4SLC6A2SLC6A3HTR2APPARA
SCHEMBL14636285 0.86 NPSR1 (0.44) SLC6A4SLC6A2SLC6A3CHRM1POLB
SCHEMBL11511051 0.83 HTR2A (0.48) SLC6A4SLC6A2SLC6A3HTR2APPARA
SCHEMBL12361548 0.81 SLC6A4 (0.54) SLC6A4SLC6A2SLC6A3HTR2APPARA
SCHEMBL13474499 0.80 SLC6A4 (0.53) SLC6A4SLC6A2SLC6A3HTR2APPARA
SCHEMBL9995323 0.78 PPARA (0.52) SLC6A4SLC6A2SLC6A3HTR2APPARA
SCHEMBL28801696 0.78 PPARA (0.54) SLC6A4SLC6A2SLC6A3HTR2APPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8779161-B2 Asenapine maleate DR. REDDY'S LABORATORIES LIMITED (IN) 2014-07-15 US disclosed
US-20130211099-A1 ASENAPINE MALEATE DR. REDDY'S LABORATORIES, INC. (US) 2013-08-15 US disclosed
EP-2582704-A2 ASENAPINE MALEATE Dr. Reddy's Laboratories Ltd. (IN) 2013-04-24 EP disclosed
WO-2011159903-A2 ASENAPINE MALEATE DR. REDDY'S LABORATORIES LTD. (IN) 2011-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130211099-A1 ASENAPINE MALEATE CYP3A5, AANAT, ADRA2C SLC6A4 17/4885SLC6A2 14/4885SLC6A3 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.